Victoria Hale


Skoll Awardee


Dr. Victoria Hale is the Founder of two nonprofit pharmaceutical companies - OneWorld Health and Medicines360. She is a pharmaceutical scientist and global health social entrepreneur. Her passion is the development of important new medicines for all of humanity, with the specific goal to reduce health inequities.
Dr Hale founded Meds360 in 2009 and was its President & CEO through 2015. Meds360 developed and obtained FDA approval for a hormonal IUD for contraception.
Dr. Hale is Founder & Chair Emeritus of One World Health, the first nonprofit pharmaceutical company in the US. She founded the company in 2000 and served as its first Chairman and CEO. Under Dr. Hale’s leadership, One World Health developed a new cure for visceral leishmaniasis, launched a novel approach to treat dehydrating diarrhea, and developed a platform technology to reduce the cost of malaria drugs by more than 10-fold. Dr. Hale established her expertise in all stages of biopharmaceutical drug development at the US Food and Drug Administration (FDA), and at Genentech. She earned her PhD in Pharmaceutical Chemistry from University of California San Francisco, where she presently maintains an Adjunct Associate Professorship in Bioengineering and Therapeutic Sciences.
Dr. Hale’s honors include being elected to membership in the Institute of Medicine of the US National Academies, and being granted the MacArthur “Genius” Award. She received the President’s Award of Distinction from the American Association of Pharmaceutical Scientists. Dr. Hale is internationally recognized as a senior social entrepreneur by the Skoll Foundation, Schwab Foundation, and Ashoka. The Economist named Victoria Hale the recipient of its Social and Economic Innovation Award.


HealthHealth Delivery